Delivery Order SPE2DB22D3016-SPE2DB24FBGR1
Award Date
9/12/24
Potential Completion Date
9/13/24
Potential Value
$1.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a delivery order contract valued at $3,273.93 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of 4,564,478,133 tablets of the medication Glimepiride 4 mg and has a period of performance through May 3, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Amerisourcebergen, valued at up to $999,999,999.00 through December 31, 2025,...
The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of GLIMEPIRIDE 4 MG TABLET 100S. The contract has a total potential value of $12,852.36 and a completion date of February 13, 2024. Amerisourcebergen Drug Corp, a for-profit organization, will perform the work from its Corporate Office location in Conshohocken, Pennsylvania. This delivery order is part of a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $3,451.03 firm fixed price delivery order is for the supply of 4564000979 - GLIMEPIRIDE 4 MG TABLET 100S, a pharmaceutical product. The contract has an ultimate completion date of March 19, 2024 and does not have any set-aside designation....
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Glimepiride 4 mg tablets. The $1,872.20 contract has a performance period through March 12, 2024. AmerisourceBergen Drug Corp is also the prime contractor on an indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025, which serves as the primary...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a major command within the U.S. Department of Defense. The contract, valued at up to $1,723.02, is for the delivery of Glimepiride 4 mg tablets. This award is a Delivery Order under an existing Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, worth up to $999,999,999.00 through December 2025. The IDC serves as...
This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The delivery order has a firm fixed price of $1,600.28 and an ultimate completion date of August 15, 2024. The contract is for the supply of 4,565,454,389 glimepiride 4 mg tablets, a generic pharmaceutical product, to support government healthcare programs. This contract award is associated with a larger Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $1,282.04 firm fixed price delivery order is for the supply of GLIMEPIRIDE 4 MG TABLET 100S, a pharmaceutical product. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, is the prime contractor on this...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Glimepiride 4 mg tablets. The order, valued at $2,388.72, is a firm fixed-price contract with an ultimate completion date of August 2, 2024. Amerisourcebergen is providing these prescription medications without any set-aside designation. This delivery order is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999, held...
This federal contract award, valued at $2,235.50, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order, with a firm-fixed price pricing type, and the ultimate completion date is April 23, 2025. The contract is for the delivery of 4,567,997,993 units of the medication Glimepiride 4 mg tablet in 100-count packages. This award does not have a set-aside designation, indicating open competition....
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $10,326.08, is for the delivery of 4,568,142,317 units of the diabetes medication Glimepiride 2 mg tablets. The contract has a period of performance through May 6, 2025 and does not utilize any set-aside designations, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery...